Men with low health literacy less likely to choose active surveillance for prostate cancer after tumor profiling
April 9, 2021 Tumor gene profiling is a tool that can help patients with a cancer diagnosis make informed decisions about treatment. In predominantly white populations, among men with early stage, favorable-risk prostate cancer, these tools have been shown to increase patient acceptance of active surveillance — a common, evidence-based approach to monitor the tumor before a more aggressive treatment, like surgery or radiation. However, a new study from researchers at the University of Illinois Chicago and Northwestern University shows that in a predominantly Black, urban patient popu...